J. L. González-Larriba, MD, PhD

Articles by J. L. González-Larriba, MD, PhD

Neoadjuvant Therapy With Cisplatin/Fluorouracil vs Cisplatin/UFT in Locally Advanced Squamous Cell Head and Neck Cancer

ByJ. L. González-Larriba, MD, PhD,I. Garcia Carbonero, MD,J. Sastre Valera, MD, PhD,P. Perez Segura, MD,Eduardo Diaz-rubio, MD, PhD

September 2nd 1997

This study compared the activity and toxicity of fluorouracil (5-FU)/cisplatin with the combination tegafur and uracil (UFT)/cisplatin in the neoadjuvant treatment of locally advanced-stage III or IV (M0)-head and neck

Latest Updated Articles

Neoadjuvant Therapy With Cisplatin/Fluorouracil vs Cisplatin/UFT in Locally Advanced Squamous Cell Head and Neck Cancer
September 2nd 1997

J. L. González-Larriba, MD, PhD

Articles by J. L. González-Larriba, MD, PhD

Neoadjuvant Therapy With Cisplatin/Fluorouracil vs Cisplatin/UFT in Locally Advanced Squamous Cell Head and Neck Cancer

Latest Updated Articles

Trending on CancerNetwork

Melanoma Vaccine Receives FDA Fast Track Designation

TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML

Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma

Second-Line Strategy After IO and TKI in Advanced Renal Cell Carcinoma

In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy